{"id":4759,"date":"2013-06-27T14:35:44","date_gmt":"2013-06-27T12:35:44","guid":{"rendered":"https:\/\/www.institut-biotherapies.fr\/?p=4759"},"modified":"2013-06-27T14:35:44","modified_gmt":"2013-06-27T12:35:44","slug":"genethon-the-french-afm-telethon-laboratory-becomes-the-first-not-for-profit-to-obtain-authorization-from-ansm-to-be-a-pharmaceutical-manufacturer","status":"publish","type":"post","link":"https:\/\/www.institut-biotherapies.fr\/en\/2013\/06\/27\/genethon-the-french-afm-telethon-laboratory-becomes-the-first-not-for-profit-to-obtain-authorization-from-ansm-to-be-a-pharmaceutical-manufacturer\/","title":{"rendered":"G\u00e9n\u00e9thon, the French AFM-Telethon laboratory, becomes the first not-for-profit to obtain authorization from ANSM to be a pharmaceutical manufacturer"},"content":{"rendered":"<p>G\u00e9n\u00e9thon, the AFM-Telethon laboratory, has received the authorization delivered by the National Agency for Drug Safety (ANSM) to become a pharmaceutical manufacturer.<br \/>\nIts production center, G\u00e9n\u00e9thon BioProd, is now authorized to produce drugs for innovative treatments. This is a first for a laboratory created by an association of patients and financed thanks to the generosity of the public, and a new stage in the emergence of innovative treatments for rare diseases.<\/p>\n<p><a title=\"Genethon, the French AFM-Telethon, become the first not-for-profit\" href=\"https:\/\/www.institut-biotherapies.fr\/wp-content\/uploads\/2013\/06\/CP-GBioprod_ENG.pdf\">&gt; Read the press release<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>G\u00e9n\u00e9thon, the AFM-Telethon laboratory, has received the authorization delivered by the National Agency for Drug Safety (ANSM) to become a pharmaceutical manufacturer. Its production center, G\u00e9n\u00e9thon BioProd, is now authorized to produce drugs for innovative treatments. This is a first for a laboratory created by an association of patients and financed thanks to the generosity &hellip; <a href=\"https:\/\/www.institut-biotherapies.fr\/en\/2013\/06\/27\/genethon-the-french-afm-telethon-laboratory-becomes-the-first-not-for-profit-to-obtain-authorization-from-ansm-to-be-a-pharmaceutical-manufacturer\/\">[Read more]<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"class_list":["post-4759","post","type-post","status-publish","format-standard","hentry","category-press-releases"],"_links":{"self":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts\/4759","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/comments?post=4759"}],"version-history":[{"count":2,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts\/4759\/revisions"}],"predecessor-version":[{"id":4763,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts\/4759\/revisions\/4763"}],"wp:attachment":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/media?parent=4759"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/categories?post=4759"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/tags?post=4759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}